Efficacy and safety of the Shexiang Baoxin Pill for the treatment of coronary artery disease not amenable to revascularisation: study protocol for a randomised, placebo-controlled, double-blinded trial - Tian, P.-p., Li, J., Gao, J., Li, Y. (BMJ Publishing, 2018)
6165057